Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Metastatic Castration Resistant Prostate Cancer
Lava TherapeuticsP2BB (65)
Pembrolizumab
Skin Carcinoma
Essen BiotechP2BB (65)
Pembrolizumab
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2BB (65)
Pembrolizumab
T-Cell Non-Hodgkin Lymphoma
Yale UniversityP2BB (65)
Pembrolizumab
Small Cell Carcinoma
Thomas Jefferson UniversityP2BB (65)
Pembrolizumab
Squamous Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer CenterP2BB (65)
TRASTUZUMAB
Gastric Adenocarcinoma
Boehringer IngelheimP2BB (65)
TRASTUZUMAB
Ovarian Carcinoma
OHSU Knight Cancer InstituteP2BB (65)
Blinatumomab
B-Cell Non-Hodgkin Lymphoma
Children's Hospital Medical Center, CincinnatiP2/3BB (65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)P2/3BB (65)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Lung Cancer
University of ChicagoP2/3BB (65)
Cetuximab
Colorectal Cancer Metastatic
Charite University, Berlin, GermanyP4BB (64)
DARATUMUMAB
Acquired Hemophilia A
Institute of Hematology & Blood Diseases Hospital, ChinaP4BB (64)
DARATUMUMAB
Hemophilia A
Institute of Hematology & Blood Diseases Hospital, ChinaP4BB (64)
DARATUMUMAB
MRD
The First Affiliated Hospital of Soochow UniversityP4BB (64)
Denosumab
Breast Cancer
Alliance for Clinical Trials in OncologyP4BB (64)
Humax-Cd20
Multiple Sclerosis
University Hospital, LilleP4BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Hemophagocytic Syndrome
The First Affiliated Hospital of Soochow UniversityP4BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Sjogren Syndrome
Peking Union Medical College HospitalP4BB (64)
PANITUMUMAB
Cancer
AmgenP4BB (64)
Atezolizumab
Bile Duct Adenocarcinoma
Georgetown UniversityP3BB (64)
Atezolizumab
Differentiated Thyroid Carcinoma
ExelixisP3BB (64)
Atezolizumab
Urethra Transitional Cell Carcinoma
Alliance for Clinical Trials in OncologyP3BB (64)
Atezolizumab
Metastatic Urethral Urothelial Carcinoma
Alliance for Clinical Trials in OncologyP3BB (64)
Atezolizumab
Colon Carcinoma
Baylor College of MedicineP3BB (64)
Showing 426 to 450 of 6,371 assets
PreviousPage 18 of 255Next